The tail vein injection model with the treatment of vismodegib targeting SMO provided further confirmation that HMGCR promoted the metastasis of HCC through the Hedgehog signaling in vivo (Fig. 7I–K). The gene discussed is HMGCR; the disease is hepatocellular carcinoma.